CN106083968B - 含葡萄糖苷结构三氮唑类去甲斑蝥素衍生物及其制备方法与应用 - Google Patents
含葡萄糖苷结构三氮唑类去甲斑蝥素衍生物及其制备方法与应用 Download PDFInfo
- Publication number
- CN106083968B CN106083968B CN201610397156.7A CN201610397156A CN106083968B CN 106083968 B CN106083968 B CN 106083968B CN 201610397156 A CN201610397156 A CN 201610397156A CN 106083968 B CN106083968 B CN 106083968B
- Authority
- CN
- China
- Prior art keywords
- triazole
- structure containing
- glucoside
- room temperature
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229930182478 glucoside Natural products 0.000 title claims abstract description 21
- -1 Triazole norcantharidin derivative Chemical class 0.000 title claims abstract description 17
- 150000008131 glucosides Chemical class 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 4
- 230000008676 import Effects 0.000 claims abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 51
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 20
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 239000005457 ice water Substances 0.000 claims description 9
- 150000003949 imides Chemical class 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- 238000003786 synthesis reaction Methods 0.000 claims description 8
- 150000003852 triazoles Chemical class 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 6
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 5
- 150000002240 furans Chemical class 0.000 claims description 5
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims description 5
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000007259 addition reaction Methods 0.000 claims description 3
- 230000033228 biological regulation Effects 0.000 claims description 3
- 238000004440 column chromatography Methods 0.000 claims description 3
- 230000003292 diminished effect Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000003456 ion exchange resin Substances 0.000 claims description 3
- 229920003303 ion-exchange polymer Polymers 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- WFBHLGOLOWZMBJ-GVYWOMJSSA-N (4r,5s,6r,7r)-1-bromo-4,5,6,7,8-pentahydroxyoctane-2,3-dione Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)C(=O)CBr WFBHLGOLOWZMBJ-GVYWOMJSSA-N 0.000 claims description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 2
- 238000005698 Diels-Alder reaction Methods 0.000 claims description 2
- 230000000118 anti-neoplastic effect Effects 0.000 claims description 2
- 230000006837 decompression Effects 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 229940071125 manganese acetate Drugs 0.000 claims description 2
- UOGMEBQRZBEZQT-UHFFFAOYSA-L manganese(2+);diacetate Chemical compound [Mn+2].CC([O-])=O.CC([O-])=O UOGMEBQRZBEZQT-UHFFFAOYSA-L 0.000 claims description 2
- 238000010189 synthetic method Methods 0.000 claims description 2
- 150000001768 cations Chemical class 0.000 claims 1
- 238000011033 desalting Methods 0.000 claims 1
- 239000011347 resin Substances 0.000 claims 1
- 229920005989 resin Polymers 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- JAABVEXCGCXWRR-FBXFSONDSA-N rel-norcantharidin Chemical group C1C[C@H]2[C@@H]3C(=O)OC(=O)[C@@H]3[C@@H]1O2 JAABVEXCGCXWRR-FBXFSONDSA-N 0.000 abstract description 14
- 239000002246 antineoplastic agent Substances 0.000 abstract description 5
- 229940041181 antineoplastic drug Drugs 0.000 abstract description 5
- 150000000177 1,2,3-triazoles Chemical class 0.000 abstract description 3
- 230000003993 interaction Effects 0.000 abstract description 2
- 230000004071 biological effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 22
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 7
- 208000005718 Stomach Neoplasms Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 206010017758 gastric cancer Diseases 0.000 description 6
- 201000011549 stomach cancer Diseases 0.000 description 6
- DHZBEENLJMYSHQ-XCVPVQRUSA-N cantharidin Chemical compound C([C@@H]1O2)C[C@@H]2[C@]2(C)[C@@]1(C)C(=O)OC2=O DHZBEENLJMYSHQ-XCVPVQRUSA-N 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 229940095758 cantharidin Drugs 0.000 description 4
- 229930008397 cantharidin Natural products 0.000 description 4
- DHZBEENLJMYSHQ-UHFFFAOYSA-N cantharidine Natural products O1C2CCC1C1(C)C2(C)C(=O)OC1=O DHZBEENLJMYSHQ-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 206010009944 Colon cancer Diseases 0.000 description 3
- 206010033128 Ovarian cancer Diseases 0.000 description 3
- 206010061535 Ovarian neoplasm Diseases 0.000 description 3
- 208000029742 colonic neoplasm Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 208000032839 leukemia Diseases 0.000 description 3
- 208000014018 liver neoplasm Diseases 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- AORTZIIKTZPIQU-UHFFFAOYSA-N 3-butyl-4-methyloxolane-2,5-dione Chemical compound CCCCC1C(C)C(=O)OC1=O AORTZIIKTZPIQU-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010073069 Hepatic cancer Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000002508 compound effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- JAABVEXCGCXWRR-UHFFFAOYSA-N norcantharidin Chemical compound C1CC2C3C(=O)OC(=O)C3C1O2 JAABVEXCGCXWRR-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/24—Heterocyclic radicals containing oxygen or sulfur as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610397156.7A CN106083968B (zh) | 2016-06-06 | 2016-06-06 | 含葡萄糖苷结构三氮唑类去甲斑蝥素衍生物及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610397156.7A CN106083968B (zh) | 2016-06-06 | 2016-06-06 | 含葡萄糖苷结构三氮唑类去甲斑蝥素衍生物及其制备方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106083968A CN106083968A (zh) | 2016-11-09 |
CN106083968B true CN106083968B (zh) | 2018-10-23 |
Family
ID=57447645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610397156.7A Active CN106083968B (zh) | 2016-06-06 | 2016-06-06 | 含葡萄糖苷结构三氮唑类去甲斑蝥素衍生物及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106083968B (zh) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101717411B (zh) * | 2009-11-19 | 2012-10-10 | 绍兴文理学院 | 去甲基斑蝥素衍生物磷酸二钠盐及其合成方法与用途 |
CN101812066A (zh) * | 2010-03-04 | 2010-08-25 | 绍兴文理学院 | 吡唑并n-取代去甲去氢斑蝥素酰亚胺衍生物及其合成方法、活性测试方法与应用 |
CN102276673B (zh) * | 2011-06-21 | 2014-12-24 | 中国科学院成都生物研究所 | 一种2-脱氧-β-D-吡喃葡萄糖基三唑类化合物的制备方法 |
CN104817605B (zh) * | 2015-04-14 | 2017-09-08 | 湖北工程学院 | 2‑(1’,2’,3’‑三氮唑‑4’‑氧苄基)‑1,3,4,6‑o‑乙酰基‑d‑葡萄糖及其制备方法和应用 |
-
2016
- 2016-06-06 CN CN201610397156.7A patent/CN106083968B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN106083968A (zh) | 2016-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103896954B (zh) | 一种吡唑类去甲斑蝥素衍生物及其制备方法与应用 | |
CN105924486B (zh) | 含麦芽糖苷结构三氮唑类去甲斑蝥素衍生物及其制备方法与应用 | |
CN106397445B (zh) | 含有色酮结构的吡唑类n-对溴苯基马来酰亚胺衍生物及其制备方法与应用 | |
CN103554135B (zh) | 一种含色酮结构异噁唑类去甲斑蝥素衍生物及其制备方法与应用 | |
CN108570086A (zh) | 含阿拉伯糖三氮唑结构的马来酰亚胺衍生物及其制备方法与应用 | |
CN103554123B (zh) | 含色酮结构吡唑类去甲斑蝥素衍生物及其制备方法与应用 | |
CN103554122B (zh) | 一种含色酮结构吡唑类去甲斑蝥素衍生物及其制备方法与应用 | |
CN107674083A (zh) | 一种含哒嗪酮结构的l‑亮氨酸取代去甲斑蝥素衍生物的制备方法及其应用 | |
CN105906678B (zh) | 氟取代含葡萄糖苷结构三氮唑类去甲斑蝥素衍生物及其制备方法与应用 | |
KR100588803B1 (ko) | 암세포주에 항암활성을 지닌 인디루빈 유도체 | |
CN106008635B (zh) | 含半乳糖苷结构三氮唑类去甲斑蝥素衍生物及其制备方法与应用 | |
CN106083966B (zh) | 氟取代含半乳糖苷结构三氮唑类去甲斑蝥素衍生物及其制备方法与应用 | |
CN106083967B (zh) | 含阿拉伯糖苷结构三氮唑类去甲斑蝥素衍生物及其制备方法与应用 | |
CN106083968B (zh) | 含葡萄糖苷结构三氮唑类去甲斑蝥素衍生物及其制备方法与应用 | |
CN106083965B (zh) | 含乳糖苷结构三氮唑类去甲斑蝥素衍生物及其制备方法与应用 | |
CN106008634B (zh) | 氟取代含阿拉伯糖苷结构三氮唑类去甲斑蝥素衍生物及其制备方法与应用 | |
CN108947916B (zh) | 一种Perimidine醌类衍生物及其制备方法和应用 | |
CN106083884B (zh) | 一种d-亮氨酸取代去甲斑蝥素衍生物及其制备方法与应用 | |
CN106083873B (zh) | 一种l-苯丙氨酸取代去甲斑蝥素衍生物及其制备方法与应用 | |
CN108570085B (zh) | 含木糖三氮唑结构的马来酰亚胺衍生物及其制备方法与应用 | |
CN108558968B (zh) | 含葡萄糖三氮唑结构的马来酰亚胺衍生物及其制备方法与应用 | |
CN103554134B (zh) | 含色酮结构异噁唑类去甲斑蝥素衍生物及其制备方法与应用 | |
CN106188081B (zh) | 一种d-缬氨酸取代去甲斑蝥素衍生物及其制备方法与应用 | |
CN103739617B (zh) | 异噁唑类去甲斑蝥素衍生物及其制备方法与应用 | |
CN107857766A (zh) | 一种基于苯丙氨酸和多羰基类环酮化合物的螺旋吲哚类化合物的合成方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191218 Address after: Room 314-1, dantaihu building (Wuluo Science Park), No.9, Taihu East Road, Wuzhong District, Suzhou, Jiangsu Province Patentee after: Suzhou ruipengcheng Technology Co.,Ltd. Address before: 312000, No. 508 West Ring Road, Yuecheng District, Zhejiang, Shaoxing Patentee before: Shaoxing University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240301 Address after: 710100 Building 6, No. 381 Kunchi 1st Road, Xiliu Street Office, High tech Zone, Xi'an City, Shaanxi Province Patentee after: Shaanxi Didu Pharmaceutical and Chemical Co.,Ltd. Country or region after: China Address before: Room 314-1, dantaihu building (Wuluo Science Park), No.9, Taihu East Road, Wuzhong District, Suzhou City, Jiangsu Province, 215100 Patentee before: Suzhou ruipengcheng Technology Co.,Ltd. Country or region before: China |